(G008) Urinary Comprehensive Genomic Profiling Predicts Urothelial Cancer Up to 12 Years Ahead of Clinical Diagnosis: An Expanded Analysis of the Golestan Cohort Study

Friday, November 17, 2023

9:15 AM – 10:15 AM MST

Speaker(s)

Brad W. Jensen, MD (he/him/his)

CLIA Medical Laboratory Director
Convergent Genomics, Inc.
Camas, Washington, United States